139 Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease

Joel Rosh; Trudy Lerer; Michael Stephens; Ryan Carvalho; Marian Pfefferkorn; Jonathan Evans; Anne Griffiths; Anothny Otley; Athos Bousvaros; Andrew Grossman; Farhat N. Ashai-Khan; Neal Leleiko; David Keljo; Marsha H. Kay; Meredith C. Hitch; Shehzad Ahmed Saeed; Maria Oliva-Hemker; David R. Mack; James Markowitz; Jeffery S. Hyams

doi:10.1016/S0016-5085(12)60139-5

139 Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease

Joel Rosh, Trudy Lerer, Michael Stephens, Ryan Carvalho, Marian Pfefferkorn, Jonathan Evans, Anne Griffiths, Anothny Otley, Athos Bousvaros, Andrew Grossman, Farhat N. Ashai-Khan, Neal Leleiko, David Keljo, Marsha H. Kay, Meredith C. Hitch, Shehzad Ahmed Saeed, Maria Oliva-Hemker, David R. Mack, James Markowitz, Jeffery S. Hyams

Wright State University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Gastroenterology
Volume	142
DOIs	https://doi.org/10.1016/S0016-5085(12)60139-5
State	Published - May 1 2012

Disciplines

Medical Specialties
Medicine and Health Sciences
Pediatrics

Access to Document

10.1016/S0016-5085(12)60139-5License: Unspecified

Cite this

Rosh, J., Lerer, T., Stephens, M., Carvalho, R., Pfefferkorn, M., Evans, J., Griffiths, A., Otley, A., Bousvaros, A., Grossman, A., Ashai-Khan, F. N., Leleiko, N., Keljo, D., Kay, M. H., Hitch, M. C., Saeed, S. A., Oliva-Hemker, M., Mack, D. R., Markowitz, J., & Hyams, J. S. (2012). 139 Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease. Gastroenterology, 142. https://doi.org/10.1016/S0016-5085(12)60139-5

Rosh, J, Lerer, T, Stephens, M, Carvalho, R, Pfefferkorn, M, Evans, J, Griffiths, A, Otley, A, Bousvaros, A, Grossman, A, Ashai-Khan, FN, Leleiko, N, Keljo, D, Kay, MH, Hitch, MC, Saeed, SA, Oliva-Hemker, M, Mack, DR, Markowitz, J & Hyams, JS 2012, '139 Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease', Gastroenterology, vol. 142. https://doi.org/10.1016/S0016-5085(12)60139-5

@article{e97dcd659c6349c190c782d9610c4fc4,

title = "139 Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease",

author = "Joel Rosh and Trudy Lerer and Michael Stephens and Ryan Carvalho and Marian Pfefferkorn and Jonathan Evans and Anne Griffiths and Anothny Otley and Athos Bousvaros and Andrew Grossman and Ashai-Khan, {Farhat N.} and Neal Leleiko and David Keljo and Kay, {Marsha H.} and Hitch, {Meredith C.} and Saeed, {Shehzad Ahmed} and Maria Oliva-Hemker and Mack, {David R.} and James Markowitz and Hyams, {Jeffery S.}",

year = "2012",

month = may,

day = "1",

doi = "10.1016/S0016-5085(12)60139-5",

language = "American English",

volume = "142",

journal = "Gastroenterology",

}

TY - JOUR

T1 - 139 Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease

AU - Rosh, Joel

AU - Lerer, Trudy

AU - Stephens, Michael

AU - Carvalho, Ryan

AU - Pfefferkorn, Marian

AU - Evans, Jonathan

AU - Griffiths, Anne

AU - Otley, Anothny

AU - Bousvaros, Athos

AU - Grossman, Andrew

AU - Ashai-Khan, Farhat N.

AU - Leleiko, Neal

AU - Keljo, David

AU - Kay, Marsha H.

AU - Hitch, Meredith C.

AU - Saeed, Shehzad Ahmed

AU - Oliva-Hemker, Maria

AU - Mack, David R.

AU - Markowitz, James

AU - Hyams, Jeffery S.

PY - 2012/5/1

Y1 - 2012/5/1

UR - https://corescholar.libraries.wright.edu/pediatrics/603

U2 - 10.1016/S0016-5085(12)60139-5

DO - 10.1016/S0016-5085(12)60139-5

M3 - Article

VL - 142

JO - Gastroenterology

JF - Gastroenterology

ER -

139 Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease

Disciplines

Access to Document

Other files and links

Cite this